Lexicon Pharmaceuticals Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 38.17, 20.15, 76.16, 99.39, 107.82 ], "ebit_estimate": [ -66.24, -95.15, -56.17, -35.32, -40.34 ], "ebitda_estimate": [ -65.73, -100.65, -52.74, -86, -46.8 ], "net_income_estimate": [ -67.39, -94.96, -52.62, -29.4, -40.04 ], "per_share_eps_estimate": [ -0.16, -0.19, -0.1, -0.03, -0.03 ], "eps_nri_estimate": [ -0.16, -0.21, -0.09, -0.03, -0.03 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -67.39, -94.96, -52.62, -29.4, -40.04 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -54.64, -65.16, -14.81, null, null ], "gross_margin_estimate": [ 98.5, 97.5, 97.5, 96.93, 98 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -0.69, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 4, 3.08, 10.02, 0.8, 0.85, 0.9, 0.9 ], "ebit_estimate": [ -21.48, -26.22, -18.4, -30.58, -29.19, -26.21, -22.95 ], "ebitda_estimate": [ -21.03, -21.71, -22.05, null, null, null, null ], "net_income_estimate": [ -21.02, -24.44, -20.87, -30.48, -28.59, -25.41, -22.25 ], "per_share_eps_estimate": [ -0.05, -0.06, -0.05, -0.06, -0.06, -0.05, -0.05 ], "eps_nri_estimate": [ -0.05, -0.06, -0.05, -0.06, -0.06, -0.05, -0.05 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -21.02, -24.44, -20.87, -30.48, -28.59, -25.41, -22.25 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ -47.03, -59.41, -51.43, null, null, null, null ], "gross_margin_estimate": [ 97, 97.67, 97.93, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -0.69, "future_operating_cash_flow_per_share_estimate_growth": null }